Multiple Sclerosis

Smoldering Disease Overview

Smoldering Disease Burden

Smoldering Disease Detection

Disease Progression Monitoring

Mechanism of Smoldering Disease

Btk Enzyme

Inside MS: Explore how BTK drives immune cell activation and CNS damage

Tolebrutinib Direct Effects on Myeloid Cells in PwMS

Discover the science behind Tolebrutinib: a BTK inhibitor designed to slow MS disability progression by modulating adaptive and innate immunity

Smoldering Neuroinflammation

Slowing of brain atrophy with Teriflunomide

Why has our brain suddenly become of interest?

The reason for MS – beyond focal inflammation

The importance of deep grey matter in MS

Thalamic atrophy as a new biomarker of MS? The predictive value and how to use in clinical practice

MS Updates

MS Newsletter

Measuring brain atrophy. What can be done and where are we heading?

How old is your brain?

Falling chronically ill – How do I cope and move forward?

Exercise as ”medicine” in the treatment of MS

Cognitive training – A curse or a blessing?

Cognitive decline – The invisible burden of MS?

A promising biomarker in MS: Neurofilament light chain